Contents - Nephrology
Immunological aspects of systemic enzyme therapy (SET) in the
complex treatment of recurrent nephrolithiasis.
Borisov A.V., Ukhal M.I., Kabak Yu.A., Borisov S.A.
Oral Enzymes in Different Animal Models of Glomerulonephritis
Emancipator S.N., Chintalacharuvu S.R., Urankar Nagy N., Stauder G.
Enzyme therapy of experimental glomerulonephritis
Emancipator S.N., Lamm M.E.
Oral enzymes in different glomerulonephritis animal models
Emancipator S.N., Nagy N.U., Chintalcharuvu S.R., Stauder G.
Beneficial effect of proteases on allograft
arteriosclerosis in a rat aortic model
Gaciong Z., Paczek L., Bojakowski K., Socha K., Wisniewski M. and Heidland A.
Enzymolysis of glomerular immune deposits in vivo with
dextranase-protease ameliorates proteinuria, hematuria, and mesangial proliferation in
murine experimental IgA nephropathy
Gesualdo L., Ricanati S., Hassan M.O., Emancipator S.N., Lamm M.E.
Malignant nephrosclerosis in Goldblatt hypertensive rats-
amelioration by systemic enzyme therapy
Heidland A., Sebekova K., Dämmrich J., Paczek L., Fierlbeck W., Krivosikova Z., Gaciong
Z.
Renal fibrosis- Role of Impaired protein degradation and
potential therapeutic strategies
Heidland A., Sebekova K., Paczek L., Teschner M., Daemmrich J., Gaciong Z.
Systemic enzyme therapy in the gout treatment
Kovalenko V.N., Siniatchenko O.V., Ignatchenko G.A., Terzov A.I., Grin V.K., Lauschkina
E.M.
Immunomodulation by proteolytic enzymes
Lehmann P.-V.
Proteolytic enzyme treatment reduces glomerular immune
deposits and proteinuria in passive Heymann nephritis
Nakazawa M., Emancipator S.N., Lamm M.E.
Proteases in the control and modulation of immunity
Nouza K., Olejár T., Nouza M.
Beneficial effect of proteases on TGF-beta production
in glomeruli from streptozotocin induced diabetes mellitus in rats
Paczek L., Gaciong Z., Bartlomiejczyk I., Czyzyk A., Heidland A.
Enzyme Therapy in Diabetic Nephropathy – Experimental and
Initial Clinical Data
Paczek L., Wood G., Stauder G., Heidland
A.
Enzyme and combination
therapy with cyclosporin A in the rat developing adjuvant arthritis
Rovenská E., Švík K., Stančíková M.,
Rovenský J.
Clinico-laboratory evaluation of treatment efficacy in chronic
pyelonephritis patients with Wobenzym
Schved N.I., Martyniuk L.P.
Systemic Ttreatment with Proteolytic Enzymes in Rat Models of
Nonimmune Mediated Renal Diseases
Sebekova K., Dammrich J., Fierlbeck W., Krivosikova Z., Paczek L., Heidland A.
Effect of Chronic Therapy with Proteolytic Enzymes on
Hypertension-Induced Renal Injury in the Rat Model of Goldblatt Hypertension
Šebeková K., Dämmrich J., Fierlbeck W., Krivosiková Z., Paczek L., Heidland
A.
The effect of oral protease administration in the rat remnant kidney model
Šebeková K., Dämmrich J., Krivošíková Z., Heidland A.
Amelioration of the progressive course of chronic
renal failure in subtotally nephrectomized rats by intraperitoneal enzyme therapy
Sebekova K., Daemmrich J., Paczek L., Gaciong Z., Blazicek P., Spustova V., Heidland
A.
Proteolytic enzymes in attenuation of tubulointerstitial fibrosis in various models of non-immune mediated renal disease
Šebeková K., Fierlbeck W., Krivošíková Z., Schinzel R., Dämmrich J.,
Galbavý Š., Blažíček P., Syrová D., Heidland A.
The effect of intraperitoneal administration of Phlogenzym on the
development of accelerated glomerulosclerosis in Goldblatt hypertensive rats (MU-697411)
Šebeková K., Heidland A., Krivošíková Z., Daemmrich J.
Amelioration of the development of chronic renal failure by
systemic enzyme treatment in the rat model of 5-6 nephrectomy
Sebekova K., Paczek L., Dämmrich J., Ling H., Schenk O., Gaciong Z., Spustova V.,
Heidland A.
Effects of Protease Therapy in the Remnant Kidney model of
Progressive Renal Failure
Sebekova K., Paczek L., Dämmrich J., Ling H., Spustova V., Gaciong Z., Heidland A.
Enzyme Therapy in Diabetic Nephropathy – Experimental and First Clinical Data
Stauder G., Wood G., Paczek L.
Systemic enzyme therapy, basic theoretical aspects, clinical application experience.
Veremeenko K.N., Kovalenko V.N.
Targeted enzyme therapy of experimental glomerulonephritis in rats
White R.B., Lowrie L., Stork J.E., Iskandar S.S., Lamm M.E., Emancipator S.N.
Advanced glycation end products impair protein turnover in LLC-PK1- Amelioration by trypsin
Xiang G., Schinzel R., Simm A., Sebekova K., Heidland A.
Advanced glycation end products (AGEs)-induced expression of TGF-b1 is suppressed by a protease in the tubule cell line LLC-PK1
Xiang G., Schinzel R., Simm A., Münch G., Sebekova
K., Kasper M., Niwa T., Schmitz Ch. and Heidland A.
Inhalt - Nephrologie 
Immunkomplexerkrankungen- Pathogenese und Therapie
Inderst R., Streichhan P., van Schaik W., Ransberger K.
Grundlagen der Behandlung immunkomplexbedingter
Erkrankungen mit Enzymen
Steffen C.
Enzymabbau von Immunkomplexen
Steffen C., Menzel J.
In-vivo-Abbau von Immunkomplexen in der Niere durch
oral applizierte Enzyme
Steffen C., Menzel J.
Materials available only in Russian 
Immunological aspects of systemic
enzyme therapy in the complex treatment of reccurent nephrolithiasis
Borisov A.V.
Dynamics of systemic and local immunity parameters in
patients with recurrent nephrolithiasis during complex therapy
Borisov A.V., Kostev F.I., Ukhal M.I., Borisov S.A.